AUD 0.81
(-1.82%)
Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|---|
Operating Cash Flow | 3.56 Million | 3.37 Million | 1.89 Million | -17.95 Million | -5.77 Million | -1.95 Million |
Net Income | -1.34 Million | -4.01 Million | -4.92 Million | -10.69 Million | -12.74 Million | -3.88 Million |
Depreciation & Amortization | 4.41 Million | 4.9 Million | 4.45 Million | 3.3 Million | 2.31 Million | 1.75 Million |
Deferred income taxes | - | -125.8 Thousand | -219.59 Thousand | -3.55 Million | -3.43 Million | 234.45 Thousand |
Stock-based compensation | - | 125.8 Thousand | 307.99 Thousand | 1.04 Million | 1.27 Million | 827.32 Thousand |
Change in working capital | -2.04 Million | 1.05 Million | 2.31 Million | -9.85 Million | 6.96 Million | -1.52 Million |
Other non-cash items | 2.53 Million | 1.43 Million | 10.4 Million | 18.56 Million | 2.25 Million | 6.01 Million |
Investing Cash Flow | -9.29 Million | -1.64 Million | -2.74 Million | -28.79 Million | -3.55 Million | -2.26 Million |
Investments in PPE | -1.16 Million | -1.28 Million | -2.49 Million | -2.9 Million | -3.08 Million | -1.98 Million |
Acquisitions | -8.12 Million | -367.64 Thousand | -244.28 Thousand | -23.18 Million | -464.85 Thousand | - |
Investment purchases | - | - | - | -2.7 Million | - | -272.07 Thousand |
Sales/Maturities of investments | - | - | - | 2.16 Million | - | - |
Other Investing Activities | -8.41 Million | -367.64 Thousand | -244.28 Thousand | -2.16 Million | -2.56 Million | -4722.00 |
Financing Cash Flow | -261.23 Thousand | -280.99 Thousand | -2.31 Million | 61.51 Million | 11.58 Million | -702.79 Thousand |
Debt repayment | -261.23 Thousand | -280.99 Thousand | -303.99 Thousand | -3.44 Million | -12.36 Million | -702.79 Thousand |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | -1.22 Million | -4.31 Million | - | - |
Common Stock Issuance | - | - | -59.39 Thousand | 70.2 Million | - | - |
Other Financing Activities | -261.23 Thousand | -280.99 Thousand | -366 Thousand | -922.01 Thousand | 10.33 Million | - |
Accounts receivables | -506.59 Thousand | 1.39 Million | -263.02 Thousand | -4.26 Million | -829.41 Thousand | -1.55 Million |
Accounts payables | 1.16 Million | -95.33 Thousand | -747.99 Thousand | -4.86 Million | 4.32 Million | 496.59 Thousand |
Inventory | -1.52 Million | -244.21 Thousand | -220.92 Thousand | 22.93 Thousand | - | - |
Other working capital | -8614.00 | -7122.00 | 3.54 Million | -746.38 Thousand | 3.46 Million | -471.36 Thousand |
Cash at beginning of period | 16.98 Million | 15.18 Million | 17.86 Million | 2.99 Million | 1.43 Million | 5.59 Million |
Cash at end of period | 10.92 Million | 16.98 Million | 15.18 Million | 17.86 Million | 2.99 Million | 1.43 Million |
Capital Expenditure | -1.16 Million | -1.28 Million | -2.49 Million | -2.9 Million | -3.08 Million | -1.98 Million |
Effect of forex changes on cash | -62.95 Thousand | 251.15 Thousand | 483.18 Thousand | 105.33 Thousand | 59.21 Thousand | 2575.00 |
Net cash flow / Change in cash | -6.05 Million | 1.79 Million | -2.67 Million | 14.87 Million | 1.55 Million | -4.15 Million |
Free Cash Flow | 2.39 Million | 2.08 Million | -602.68 Thousand | -20.86 Million | -8.86 Million | -3.94 Million |
Breakdown | 2024 FY | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | -1.34 Million | -65.81 Thousand | -65.81 Thousand | -1.2 Million | -604.68 Thousand | -4.01 Million |
Depreciation & Amortization | 4.41 Million | 1.08 Million | 1.08 Million | 2.23 Million | 632.75 Thousand | 4.9 Million |
Deferred income taxes | - | - | - | - | - | -125.8 Thousand |
Stock-based compensation | - | - | - | - | - | 125.8 Thousand |
Change in working capital | -475.36 Thousand | -1.02 Million | -1.02 Million | - | - | 1.05 Million |
Other non-cash items | 10.66 Million | -46.59 Thousand | -46.59 Thousand | 7.11 Million | 1.8 Million | 1.43 Million |
Investing Cash Flow | -9.29 Million | -297.48 Thousand | -297.48 Thousand | -8.7 Million | -4.35 Million | -1.64 Million |
Investments in PPE | -1.16 Million | -279.25 Thousand | -279.25 Thousand | -572.45 Thousand | -161.93 Thousand | -1.28 Million |
Acquisitions | - | 8.12 Million | - | -8.12 Million | -4.06 Million | -367.64 Thousand |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | -8.12 Million | -18.23 Thousand | -18.23 Thousand | -124.29 Thousand | -124.29 Thousand | -367.64 Thousand |
Financing Cash Flow | -261.23 Thousand | -80.85 Thousand | -80.85 Thousand | -99.53 Thousand | -49.76 Thousand | -280.99 Thousand |
Debt repayment | - | - | - | - | - | -280.99 Thousand |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | - | -80.85 Thousand | -80.85 Thousand | -49.76 Thousand | -49.76 Thousand | -280.99 Thousand |
Accounts receivables | -506.59 Thousand | -253.29 Thousand | -253.29 Thousand | - | - | 1.39 Million |
Accounts payables | 1.16 Million | - | - | - | - | -95.33 Thousand |
Inventory | -1.52 Million | -762.7 Thousand | -762.7 Thousand | - | - | -244.21 Thousand |
Other working capital | 393.68 Thousand | -4307.00 | -4307.00 | - | - | -7122.00 |
Cash at beginning of period | 16.98 Million | 11.66 Million | - | 16.98 Million | - | 15.18 Million |
Cash at end of period | 10.92 Million | 10.92 Million | -369.81 Thousand | 11.66 Million | -2.65 Million | 16.98 Million |
Capital Expenditure | -1.16 Million | -279.25 Thousand | -279.25 Thousand | -572.45 Thousand | -161.93 Thousand | -1.28 Million |
Effect of forex changes on cash | - | 55.89 Thousand | 55.89 Thousand | -87.37 Thousand | -87.37 Thousand | 251.15 Thousand |
Net cash flow / Change in cash | -6.05 Million | -739.63 Thousand | -369.81 Thousand | -5.31 Million | -2.65 Million | 1.79 Million |
Free Cash Flow | 2.39 Million | -326.63 Thousand | -326.63 Thousand | 3.08 Million | 1.66 Million | 2.08 Million |
0HOJ
0058
ENTRA
001338
INDSILHYD
LAFFANSQ